This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| International Myopia Institute | |
|---|---|
| Name | International Myopia Institute |
| Formation | 2015 |
| Type | Non-profit research consortium |
| Headquarters | Rotterdam |
| Region served | Global |
| Leader title | Founding Chair |
| Leader name | Serge Resnikoff |
International Myopia Institute is an international consortium focused on coordinating research, public health policy, and clinical practice around myopia. Founded to address rising prevalence in East Asia, Europe, North America, and Australasia, the institute convenes ophthalmologists, optometrists, epidemiologists, and public health leaders to produce consensus statements and translational guidance. It engages with global organizations, academic institutions, professional societies, and regulatory bodies to harmonize myopia management strategies.
The institute was established amid increasing reports from World Health Organization meetings, Royal College of Ophthalmologists conferences, and regional symposia such as the Asia-Pacific Academy of Ophthalmology assemblies. Early activity drew on work presented at Association for Research in Vision and Ophthalmology sessions and policy discussions involving the United Nations and World Health Organization experts on visual impairment. Founders included clinicians and researchers previously affiliated with Harvard Medical School, University College London, National University of Singapore, and Zhejiang University, who responded to epidemiological evidence from studies published by groups at Peking University, Kyoto University, and University of Sydney. Initial meetings were held alongside events like the American Academy of Optometry congress and the European Society of Cataract and Refractive Surgeons symposium, fostering early collaboration with organizations such as the International Agency for the Prevention of Blindness and the Brien Holden Vision Institute.
The institute’s mission aligns with recommendations from the World Health Assembly and the Global Burden of Disease Study to mitigate visual impairment caused by progressive myopia. Objectives emphasize translational research, standardized terminology, and clinical practice guidelines similar to initiatives led by the National Eye Institute and the National Health Service advisory panels. Key goals include synthesizing data from cohorts like the Blue Mountains Eye Study, the Beaver Dam Eye Study, and the Singapore Chinese Eye Study to inform policy endorsed by agencies such as the Centers for Disease Control and Prevention and the European Commission health units.
Governance models reflect structures used by organizations including the International Council of Ophthalmology, the International Agency for Research on Cancer, and the Cochrane Collaboration. Leadership comprises an international board with representatives from institutions such as Moorfields Eye Hospital, Johns Hopkins University, University of Oxford, and Charité – Universitätsmedizin Berlin. Advisory panels include members from the American Academy of Ophthalmology, the World Council of Optometry, and the Pan American Health Organization, while working groups parallel task forces seen at the National Institute for Health and Care Excellence and the Royal Australian and New Zealand College of Ophthalmologists.
Programmatic activity includes consensus output comparable to reports from the Lancet Commission and guideline development akin to the USPSTF processes. Initiatives include standardized definitions adopted by groups such as the International Myopia Management Guidelines Committee, large-scale data harmonization projects reminiscent of efforts by the Human Genome Project consortia, and public awareness campaigns coordinated with partners like Sightsavers and Orbis International. Educational programs have been delivered at meetings hosted by the World Ophthalmology Congress, the Asia Pacific Academy of Ophthalmology, and the American Academy of Ophthalmology.
The institute produces comprehensive statements, reviews, and consensus papers published alongside journals like Ophthalmology, JAMA Ophthalmology, The Lancet Global Health, and Investigative Ophthalmology & Visual Science. Research priorities mirror topics explored at the Association for Research in Vision and Ophthalmology and include genetic epidemiology tied to findings from 23andMe-linked studies, environmental risk analyses comparable to work from the University of California, Berkeley, and interventional trials inspired by protocols used at Moorfields Eye Hospital and Children’s Hospital of Philadelphia. Major publications synthesize data from cohort studies such as the ALSPAC birth cohort, the Generation R Study, and the Rotterdam Study.
Collaborative networks reflect partnerships common to entities like the Global Alliance for Eye Health and the Vision Loss Expert Group. The institute works with academic partners including University of Melbourne, Peking Union Medical College Hospital, and Seoul National University Hospital, and with professional societies such as the American Optometric Association and the College of Optometrists (UK). Engagement extends to funding bodies and NGOs including the Bill & Melinda Gates Foundation, the Wellcome Trust, and The Fred Hollows Foundation on programmatic and research initiatives.
The institute has influenced policy statements adopted by national health ministries in countries including Singapore, China, Japan, Australia, and United Kingdom—echoing the policy uptake seen with work from the Global Burden of Disease Study and the World Health Organization. Its consensus guidelines have informed clinical pathways in tertiary centers such as Bascom Palmer Eye Institute and Singapore National Eye Centre, and have shaped curriculum updates at academic centers like Imperial College London and University of California, San Francisco. The institute’s data harmonization efforts have enabled meta-analyses comparable to those produced by collaborations including the UK Biobank and multinational consortia, strengthening evidence for interventions used in trials at Great Ormond Street Hospital and elsewhere.
Category:Ophthalmology organizations Category:Eye care